MYGN

Myriad Genetics (MYGN)

About Myriad Genetics (MYGN)

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Details

Daily high

$4.57

Daily low

$4.36

Price at open

$4.50

52 Week High

$15.47

52 Week Low

$3.76

Market cap

419.5M

Dividend yield

0.00%

Volume

85,291

Avg. volume

954,727

P/E ratio

-1.04

Myriad Genetics News